Sort by:
Need a comprehensive medical report on "A"?
Analyze the latest clinical research and treatment options
Summarize scientific findings from medical journals
A Study in Healthy People to Compare How 2 Different Formulations of Survodutide Are Taken up in the Body
Not Applicable
Not yet recruiting
- Conditions
- Healthy
- Interventions
- Drug: BI 456906 formulation ADrug: BI 456906 formulation B2
- First Posted Date
- 2025-07-18
- Last Posted Date
- 2025-07-18
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 16
- Registration Number
- NCT07071974
- Locations
- 🇩🇪
CRS Clinical Research Services Berlin GmbH, Berlin, Germany
A Multicenter, Prospective, Observational, Open-label Study to Evaluate the Benefit of Corticoid Sparing in Elderly With Generalized AntiRAch Myasthenia Gravis Treated With IV or SC Efgartigimod
Not Applicable
Not yet recruiting
- Conditions
- Myasthenia Gravis, Generalized
- Interventions
- First Posted Date
- 2025-07-18
- Last Posted Date
- 2025-07-18
- Lead Sponsor
- Centre Hospitalier Universitaire de Nice
- Target Recruit Count
- 50
- Registration Number
- NCT07072988
A Single-centre Study Evaluating the Performance and Acceptance of the Hilo Band Cuffless Blood Pressure Medical Device in the Normo-, Hypo- and Hyper-tensive Young Population: a Comparison With the 24-h Ambulatory Blood Pressure Monitoring (ABPM)
Not yet recruiting
- Conditions
- Hypertension
- First Posted Date
- 2025-07-18
- Last Posted Date
- 2025-07-18
- Lead Sponsor
- Simonetti Giacomo
- Target Recruit Count
- 40
- Registration Number
- NCT07072689
- Locations
- 🇨🇭
Ente Ospedaliero Cantonale, Bellinzona, Switzerland
DEB-BACE for Primary Lung Cancer: A Retrospective, Single-Arm, Multicenter Study on Efficacy and Safety
Not yet recruiting
- Conditions
- Lung Cancer Patients
- First Posted Date
- 2025-07-18
- Last Posted Date
- 2025-07-18
- Lead Sponsor
- Gang Wu, MD
- Target Recruit Count
- 1213
- Registration Number
- NCT07072299
A US Study to Look at Loss of Work and Healthcare Costs for People Affected With Mild-to-moderate COVID 19 Who Have High Chances of the Disease Becoming Severe
Completed
- Conditions
- COVID-19 (Coronavirus Disease 2019)
- Interventions
- Drug: nirmatrelvir-ritonavir
- First Posted Date
- 2025-07-18
- Last Posted Date
- 2025-07-18
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 84584
- Registration Number
- NCT07072793
- Locations
- 🇺🇸
Pfizer New York, New York, New York, United States
A Study to Evaluate the Efficacy and Safety of IN-115314 Ointment in Mild to Moderate Atopic Dermatitis Adult Patients
Not Applicable
Not yet recruiting
- Conditions
- Mild to Moderate Atopic Dermatitis
- Interventions
- Drug: IN-115314 Ointment 1%Drug: IN-115314 Ointment 3%Drug: IN-115314 Ointment placebo
- First Posted Date
- 2025-07-18
- Last Posted Date
- 2025-07-18
- Lead Sponsor
- HK inno.N Corporation
- Target Recruit Count
- 162
- Registration Number
- NCT07073677
CD19 CAR-T Cell Infusion as Consolidation Therapy in Adolescent and Adult Patients With Acute B-ALL Ineligible for Allogeneic HSCT: A Clinical Study
Not Applicable
Recruiting
- Conditions
- Acute Lymphoblastic Leukemia
- Interventions
- Drug: CD19 CAR-T cells injection
- First Posted Date
- 2025-07-18
- Last Posted Date
- 2025-07-18
- Lead Sponsor
- Zhujiang Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT07072494
- Locations
- 🇨🇳
Zhujiang Hospital, Guangzhou, Guangdong, China
A Study of GC012F (AZD0120), a CAR T Therapy Targeting CD19 and BCMA in Early-Line Treatment in Subjects With Multiple Myeloma
Not Applicable
Recruiting
- Conditions
- Newly Diagnosed Multiple MyelomaRelapsed Refractory Multiple Myeloma
- Interventions
- Biological: GC012F (AZD0120)
- First Posted Date
- 2025-07-18
- Last Posted Date
- 2025-07-18
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 18
- Registration Number
- NCT07073547
- Locations
- 🇺🇸
Research site, New York, New York, United States
A Study Comparing Restrictive and Liberal Fluid Therapy During Pancreatecoduodenectomy Surgery
Not Applicable
Completed
- Conditions
- Pancreatic Cancer, ResectedWhipple Procedure
- First Posted Date
- 2025-07-18
- Last Posted Date
- 2025-07-18
- Lead Sponsor
- Tribhuvan University Teaching Hospital, Institute Of Medicine.
- Target Recruit Count
- 44
- Registration Number
- NCT07072897
- Locations
- 🇳🇵
Tribhuvan University Teaching Hospital, Kathmandu, Bagmati, Nepal
The Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Training Period.
Not Applicable
- Conditions
- Myotonic Dystrophy 1Inclusion Body MyositisMyotonic Dystrophy 2Facio-Scapulo-Humeral DystrophyGuillain Barré SyndromeFriedreich AtaxiaLimb Girdle Muscular DystrophiesPompe Disease (Infantile-Onset)Lambert Eaton (LEMS)Myasthaenia Gravis
- First Posted Date
- 2025-07-18
- Last Posted Date
- 2025-07-18
- Lead Sponsor
- LMU Klinikum
- Target Recruit Count
- 30
- Registration Number
- NCT07072676
- Locations
- 🇩🇪
Medical Park, Bad Feilnbach, Reithofpark, Bad Feilnbach, Germany